American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, … Read more
American Oncology Network Inc. (AONC) - Total Liabilities
Latest total liabilities as of December 2024: $362.32 Million USD
Based on the latest financial reports, American Oncology Network Inc. (AONC) has total liabilities worth $362.32 Million USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
American Oncology Network Inc. - Total Liabilities Trend (2020–2024)
This chart illustrates how American Oncology Network Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
American Oncology Network Inc. Competitors by Total Liabilities
The table below lists competitors of American Oncology Network Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dongnan Electronics Co. Ltd. A
SHE:301359
|
China | CN¥58.45 Million |
|
Century Therapeutics Inc
NASDAQ:IPSC
|
USA | $68.37 Million |
|
AM Locales Property Socimi
MC:YAML
|
Spain | €58.86 Million |
|
Shinsegae Inte
KO:031430
|
Korea | ₩567.22 Billion |
|
Share India Securities Limited
NSE:SHAREINDIA
|
India | ₹18.08 Billion |
|
Tah Hsin Industrial Corp
TW:1315
|
Taiwan | NT$697.31 Million |
|
Kaltura Inc
NASDAQ:KLTR
|
USA | $154.89 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down American Oncology Network Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 19.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how American Oncology Network Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for American Oncology Network Inc. (2020–2024)
The table below shows the annual total liabilities of American Oncology Network Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $362.32 Million | +19.29% |
| 2023-12-31 | $303.74 Million | +14.96% |
| 2022-12-31 | $264.21 Million | +1087.12% |
| 2021-12-31 | $22.26 Million | +89395.13% |
| 2020-12-31 | $24.87K | -- |